Advertisement
UK markets close in 2 hours 22 minutes
  • FTSE 100

    8,067.62
    +27.24 (+0.34%)
     
  • FTSE 250

    19,659.97
    -59.40 (-0.30%)
     
  • AIM

    754.45
    -0.24 (-0.03%)
     
  • GBP/EUR

    1.1671
    +0.0026 (+0.22%)
     
  • GBP/USD

    1.2473
    +0.0011 (+0.09%)
     
  • Bitcoin GBP

    50,593.83
    -2,444.99 (-4.61%)
     
  • CMC Crypto 200

    1,350.40
    -32.17 (-2.33%)
     
  • S&P 500

    5,071.63
    +1.08 (+0.02%)
     
  • DOW

    38,460.92
    -42.77 (-0.11%)
     
  • CRUDE OIL

    82.87
    +0.06 (+0.07%)
     
  • GOLD FUTURES

    2,344.10
    +5.70 (+0.24%)
     
  • NIKKEI 225

    37,628.48
    -831.60 (-2.16%)
     
  • HANG SENG

    17,284.54
    +83.27 (+0.48%)
     
  • DAX

    17,909.40
    -179.30 (-0.99%)
     
  • CAC 40

    7,984.10
    -107.76 (-1.33%)
     

The Performance of Roche’s Diagnostics Division in Q1 2018

The Performance of Roche’s Diagnostics Division in Q1 2018

Roche’s (RHHBY) Diagnostics division comprises tissue diagnostics, molecular diagnostics, diabetes care, and centralized and point-of-care solutions. Roche’s Diagnostics division grew 5.0% year-over-year to reach ~2.9 billion Swiss francs.